Zobrazeno 1 - 10
of 12
pro vyhledávání: '"April Went"'
Autor:
Hamish Innes, Philip Johnson, Scott A. McDonald, Victoria Hamill, Alan Yeung, John F. Dillon, Peter C. Hayes, April Went, Stephen T. Barclay, Andrew Fraser, Andrew Bathgate, David J. Goldberg, Sharon J. Hutchinson
Publikováno v:
Gastro Hep Advances, Vol 1, Iss 2, Pp 129-136 (2022)
Background and Aims: Existing models predicting hepatocellular carcinoma (HCC) occurrence do not account for competing risk events and, thus, may overestimate the probability of HCC. Our goal was to quantify this bias for patients with cirrhosis and
Externí odkaz:
https://doaj.org/article/0c07933401ed4fc3987fd1207e72b9fd
Autor:
Hamish Innes, Peter Jepsen, Scott McDonald, John Dillon, Victoria Hamill, Alan Yeung, Jennifer Benselin, April Went, Andrew Fraser, Andrew Bathgate, M. Azim Ansari, Stephen T. Barclay, David Goldberg, Peter C. Hayes, Philip Johnson, Eleanor Barnes, William Irving, Sharon Hutchinson, Indra Neil Guha
Publikováno v:
JHEP Reports, Vol 3, Iss 6, Pp 100384- (2021)
Background & Aims: Hepatocellular carcinoma (HCC) prediction models can inform clinical decisions about HCC screening provided their predictions are robust. We conducted an external validation of 6 HCC prediction models for UK patients with cirrhosis
Externí odkaz:
https://doaj.org/article/776f0b9432e44ddca1f7bb8a8c5de874
Epidemiology of SARS-CoV-2 during the first three waves in Scotland: a national record linkage study
Autor:
Kirstin Leslie, Beth Findlay, Theresa Ryan, Leonardo I Green, Ciaran Harvey, Alice E Whettlock, Jen Bishop, Vicki Ponce Hardy, April Went, Lesley Wallace, Allan McLeod, Amanda Weir, Kimberly Marsh
Publikováno v:
Journal of Epidemiology and Community Health. 77:1-8
BackgroundThe early COVID-19 pandemic in Scotland—defined as the era before widespread access to vaccination and monoclonal antibody treatment—can be characterised into three distinct waves: March–July 2020, July 2020–April 2021 and May–Aug
Autor:
Hamish Innes, Victoria Hamill, Scott A. McDonald, Peter C. Hayes, Philip Johnson, John F. Dillon, Jen Bishop, Alan Yeung, April Went, Stephen T. Barclay, Andrew Fraser, Andrew Bathgate, David J. Goldberg, Sharon J. Hutchinson
Publikováno v:
American Journal of Gastroenterology. 117:1454-1461
Autor:
Hamish Innes, Scott A. McDonald, Victoria Hamill, Alan Yeung, John F. Dillon, Peter C. Hayes, April Went, Andrew Fraser, Andrew Bathgate, Stephen T. Barclay, Naveed Janjua, David J. Goldberg, Sharon J. Hutchinson
Publikováno v:
Innes, H A, McDonald, S A, Hamill, V, Yeung, A, Dillon, J F, Hayes, P C, Went, A, Fraser, A, Bathgate, A J, Barclay, S T, Janjua, N Z, Goldberg, D J & Hutchinson, S J 2022, ' Declining incidence of hepatitis C related hepatocellular carcinoma in the era of interferon-free therapies : a population-based cohort study ', Liver International, vol. 42, no. 3, pp. 561-574 . https://doi.org/10.1111/liv.15143
BACKGROUND & AIMS:The impact of interferon (IFN)-free therapies on the epidemiology of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) is not well understood at a population level. Our goal was to bridge this evidence gap.METHODS: This
Autor:
Sharon J. Hutchinson, April Went, Peter C. Hayes, David J. Goldberg, Andrew Fraser, Stephen T. Barclay, Scott A. McDonald, John F. Dillon, Hamish Innes, Andrew Bathgate
Publikováno v:
Journal of viral hepatitisREFERENCES. 28(9)
Interferon-free DAA therapies have recently been licensed for patients infected with hepatitis C virus (HCV) who have decompensated cirrhosis (DC). Our aim was to describe factors associated with uptake of IFN-free DAAs in DC patients and to compare
Autor:
Stuart J McGurnaghan, Amanda Weir, Jen Bishop, Sharon Kennedy, Luke A K Blackbourn, David A McAllister, Sharon Hutchinson, Thomas M Caparrotta, Joseph Mellor, Anita Jeyam, Joseph E O'Reilly, Sarah H Wild, Sara Hatam, Andreas Höhn, Marco Colombo, Chris Robertson, Nazir Lone, Janet Murray, Elaine Butterly, John Petrie, Brian Kennon, Rory McCrimmon, Robert Lindsay, Ewan Pearson, Naveed Sattar, John McKnight, Sam Philip, Andrew Collier, Jim McMenamin, Alison Smith-Palmer, David Goldberg, Paul M McKeigue, Helen M Colhoun, Alice Whettlock, Allan McLeod, Andrew Gasiorowski, Andrew Merrick, Andy McAuley, April Went, Calum Purdie, Colin Fischbacher, Colin Ramsey, David Bailey, David Henderson, Eisin McDonald, Genna Drennan, Graeme Gowans, Graeme Reid, Heather Murdoch, Jade Carruthers, Josie Murray, Karen Heatlie, Lorraine Donaldson, Martin Paton, Martin Reid, Melissa Llano, Michelle Murphy-Hall, Ross Hall, Ross Cameron, Susan Brownlie, Adam Gaffney, Aynsley Milne, Christopher Sullivan, Edward McArdle, Elaine Glass, Johanna Young, William Malcolm, Jodie McCoubrey
Publikováno v:
2020, ' Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland ', The Lancet Diabetes and Endocrinology . https://doi.org/10.1016/S2213-8587(20)30405-8
The Lancet Diabetes & Endocrinology
The Lancet. Diabetes & Endocrinology
The Lancet Diabetes & Endocrinology
The Lancet. Diabetes & Endocrinology
SHu reports grants from Health Protection Scotland during the conduct of the study. TMC reports grants from Diabetes UK (18/0005786). CR reports grants from Public Health Scotland and UK Research and Innovation. Background We aimed to ascertain the c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b38f30510c88bffe42e7454b329403ba
https://hdl.handle.net/10023/25155
https://hdl.handle.net/10023/25155
Autor:
Kevin G.J. Pollock, Allan McLeod, David J. Goldberg, Sharon J. Hutchinson, Scott A. McDonald, Stephen T. Barclay, Rory Gunson, April Went
Publikováno v:
Journal of viral hepatitisREFERENCES. 27(10)
Following positive serology, the gold standard confirmatory test of hepatitis C virus (HCV) infection is detection of HCV RNA by PCR. We assessed the utility of HCV core antigen testing to identify active infection among those positive for anti-HCV a
Autor:
Andrew Fraser, Eleanor Barnes, Alan Yeung, Sharon J. Hutchinson, Stephen T. Barclay, Indra Neil Guha, Jennifer Benselin, Philip J. Johnson, Peter Uhd Jepsen, Victoria Hamill, Andrew Bathgate, William L. Irving, April Went, Hamish Innes, David J. Goldberg, Peter C. Hayes, M. Azim Ansari, Scott A. McDonald, John F. Dillon
Publikováno v:
Innes, H, Jepsen, P, McDonald, S, Dillon, J, Hamill, V, Yeung, A, Benselin, J, Went, A, Fraser, A, Bathgate, A, Ansari, M A, Barclay, S T, Goldberg, D, Hayes, P C, Johnson, P, Barnes, E, Irving, W, Hutchinson, S & Guha, I N 2021, ' Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured HCV infection ', JHEP Reports, vol. 3, no. 6, 100384 . https://doi.org/10.1016/j.jhepr.2021.100384
JHEP REPORTS
JHEP Reports
JHEP Reports, Vol 3, Iss 6, Pp 100384-(2021)
JHEP REPORTS
JHEP Reports
JHEP Reports, Vol 3, Iss 6, Pp 100384-(2021)
Background & Aims Hepatocellular carcinoma (HCC) prediction models can inform clinical decisions about HCC screening provided their predictions are robust. We conducted an external validation of 6 HCC prediction models for UK patients with cirrhosis
Autor:
Sharon J. Hutchinson, Peter C. Hayes, J. Morris, April Went, Kevin G.J. Pollock, Stephen T. Barclay, Andrew Fraser, Peter Bramley, Andrew Bathgate, John F. Dillon, David J Goldberg, Nicholas A. Kennedy, Hamish Innes, Scott A. McDonald
Publikováno v:
McDonald, S A, Pollock, K G J, Barclay, S T, Goldberg, D J, Bathgate, A J, Bramley, P, Dillon, J, Fraser, A, Innes, H, Kennedy, N, Morris, J, Went, A, Hayes, P & Hutchison, S 2020, ' Real-world impact following initiation of interferon-free hepatitis C regimens on liver-related outcomes and all-cause mortality among patients with compensated cirrhosis ', Journal of Viral Hepatitis . https://doi.org/10.1111/jvh.13232
Few studies have investigated clinical outcomes among patients with cirrhosis who were treated with interferon (IFN)-free direct-acting antiviral (DAA). We aimed to quantify treatment impact on first decompensated cirrhosis hospital admission, first